BiomX News

BiomX to Present at the 2024 RBC Capital Markets Global Healthcare Conference

CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 06, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a clinical-stage company advancing novel natural and engineered phage therapies that target

GlobeNewswireMay 6 07:00 ET

12 Health Care Stocks Moving In Tuesday's After-Market Session

GainersPredictive Oncology (NASDAQ:POAI) shares rose 36.4% to $1.95 during Tuesday's after-market session. The company's market cap stands at $7.9 million. Brainstorm Cell (NASDAQ:BCLI) shares moved u

BenzingaApr 30 16:31 ET

BiomX Files to Sell 120.15M Warrants for Holders

Seeking AlphaApr 29 16:43 ET

12 Health Care Stocks Moving In Wednesday's After-Market Session

GainersAcrivon Therapeutics (NASDAQ:ACRV) stock rose 12.3% to $10.67 during Wednesday's after-market session. The market value of their outstanding shares is at $329.4 million. Amarin Corp (NASDAQ:AMR

BenzingaApr 24 16:31 ET

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

GainersImmutep (NASDAQ:IMMP) stock increased by 15.5% to $2.9 during Wednesday's pre-market session. The market value of their outstanding shares is at $344.7 million. Syra Health (NASDAQ:SYRA) stock

BenzingaApr 24 08:06 ET

Express News | BiomX To Present Data From Phase 1b/2a Study Of BX004 For Treatment Of Cystic Fibrosis Patients With Chronic Pulmonary Infections At 34th European Congress Of Clinical Microbiology And Infectious Diseases

Moomoo 24/7Apr 23 08:11 ET

BiomX to Present Data From Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients With Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)

Abstract selected as a "Top Poster", ranking it among the 1-2% of top-rated abstracts in the category submitted and accepted at ECCMID 2024CAMBRIDGE, Mass. and NESS ZIONA, Israel, April 23, 2024 (GL

GlobeNewswireApr 23 08:00 ET

BiomX's BX211 Phage Therapy: A Revolutionary Approach to Diabetic Foot Osteomyelitis Treatment

TipRanksApr 22 06:16 ET

Express News | Biomx Announces the Appointment of Susan Blum to Its Board of Directors

Moomoo 24/7Apr 18 08:00 ET

Press Release: BiomX Announces the Appointment of Susan Blum to Its Board of Directors

BiomX Announces the Appointment of Susan Blum to its Board of Directors CAMBRIDGE, Mass. and NESS ZIONA, Israel, April 18, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) ("BiomX" or the "C

Dow JonesApr 18 08:00 ET

BiomX Board Governance Structure and Bylaws Updated

TipRanksApr 15 17:32 ET

Express News | Biomx Inc - on April 11, Increased the Size of the Board to Eight Members

Moomoo 24/7Apr 15 17:21 ET

Biomx Inc. at a Crossroads: Shareholder Approval Required for Convertible Securities Amid Liquidity Concerns

TipRanksApr 5 02:00 ET

Express News | BiomX Announces Compliance With NYSE Guidelines On Audit Opinion Disclosure

Moomoo 24/7Apr 4 07:50 ET

Express News | BiomX Q4 EPS $(0.08) Up From $(0.20) YoY

Moomoo 24/7Apr 3 23:26 ET

Analysts Are Bullish on These Healthcare Stocks: BiomX (PHGE), Daré Bioscience (DARE)

TipRanksApr 3 14:50 ET

Earnings Call Summary | BiomX(PHGE.US) Q4 2023 Earnings Conference

The following is a summary of the BiomX Inc. (PHGE) Q4 2023 Earnings Call Transcript:Financial Performance:BiomX reported a decrease in cash balance and short-term deposits from $34.3 million as of 20

moomoo AIApr 3 12:31 ET · Conference Call

BiomX's Robust Financial Health and Promising Clinical Advancements Bolster Buy Rating

TipRanksApr 3 10:35 ET

Express News | BiomX's 2023 Cash Balance, Short-Term Deposits And Restricted Cash Of $15.9M And Concurrent $50M Financing Is Expected To Provide Cash Runway Into 2025

Moomoo 24/7Apr 3 06:37 ET

Express News | BiomX FY EPS $(0.51) Up From $(0.95) YoY

Moomoo 24/7Apr 3 06:35 ET